MFIMFI
HAE icon

Mesirow Financial Investment Management - Fixed Income’s Haemonetics HAE Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-69,655
Closed -$7.73M – 139
2021
Q1 		$7.73M Sell
69,655
-1,895
-3% -$234K 0.9% 61
2020
Q4 		$8.5M Sell
71,550
-765
-1% -$82.4K 1.14% 27
2020
Q3 		$6.31M Buy
+72,315
New +$6.32M 1.07% 31

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's HAE Position: Q2 2021 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 69,655 shares — an estimated $7.73M sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in HAE in Q3 2020 and held it in 3 quarters. The position peaked at $8.5M in Q4 2020. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

  • Mesirow Financial Investment Management - Fixed Income reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
  • Mesirow Financial Investment Management - Fixed Income sold 69,655 Haemonetics shares in Q2 2021, an estimated $7.73M.
  • Mesirow Financial Investment Management - Fixed Income first reported a position in Haemonetics in Q3 2020 and held it in 3 quarters.
  • Mesirow Financial Investment Management - Fixed Income's Haemonetics position peaked at $8.5M in Q4 2020.
  • 258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q2 2021, filed 3 Aug 2021.